SCHEMBL18946718

SCHEMBL18946718

CNc1c(O)ccc(CCNCCCCCOc2cccc(C(=O)NC3(C)Cc4ccccc4C3)c2)c1/C=C\C=O

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 3/20 0.36
▸ SMPD1 P17405 3/20 0.35
▸ GPR132 Q9UNW8 1/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ NAMPT P43490 1/20 0.34
▸ PRMT5 O14744 2/20 0.34
▸ WDR77 Q9BQA1 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ KMT2A Q03164 2/20 0.33
▸ F10 P00742 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ HCN1 O60741 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18946467 0.76 ADRB2 (0.40) MAOBKDM4EPRMT5WDR77LMNA
SCHEMBL21517317 0.66 SLC5A1 (0.41) KMT2ALMNAMAPTSMN1; SMN2
SCHEMBL23223736 0.65 ADRB2 (0.39) KDM4EALDH1A1GAALMNA
SCHEMBL22839931 0.62 XDH (0.35) KDM4EALDH1A1KMT2AMAPTMAPK1
SCHEMBL23223711 0.61 HTR2A (0.38) —
SCHEMBL14384310 0.60 KMT2A (0.63) MAOBKDM4EALDH1A1GAAKMT2A
SCHEMBL14384316 0.60 PLA2G4B (0.69) SMPD1KDM4EALDH1A1GAAKMT2A
SCHEMBL14383496 0.60 PLA2G4B (0.69) SMPD1KDM4EALDH1A1GAAKMT2A
SCHEMBL18595089 0.59 PLA2G4B (0.67) SMPD1KDM4EALDH1A1GAAKMT2A
SCHEMBL22839824 0.59 HDAC1 (0.39) NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017093208-A1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARMACEUTICI S.P.A. (IT) 2017-06-08 — — WO disclosed
Send feedback